174 related articles for article (PubMed ID: 36565726)
1. Cathepsin protease expression in infiltrative soft tissue sarcomas: cathepsin-K correlates with infiltrative tumor growth and clinical outcomes.
Fujiwara T; Zhang L; Chandler A; Sung S; Yakoub M; Linkov I; Hameed M; Healey JH
Hum Pathol; 2023 Apr; 134():30-44. PubMed ID: 36565726
[TBL] [Abstract][Full Text] [Related]
2. Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma.
Iwata S; Yonemoto T; Araki A; Ikebe D; Kamoda H; Hagiwara Y; Ishii T
J Surg Oncol; 2014 Nov; 110(6):707-11. PubMed ID: 24975462
[TBL] [Abstract][Full Text] [Related]
3. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas.
Würl P; Taubert H; Meye A; Dansranjavin T; Weber E; Günther D; Berger D; Schmidt H; Dralle H; Rath FW
Virchows Arch; 1997 Mar; 430(3):221-5. PubMed ID: 9099979
[TBL] [Abstract][Full Text] [Related]
5. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
Nakayama R; Nemoto T; Takahashi H; Ohta T; Kawai A; Seki K; Yoshida T; Toyama Y; Ichikawa H; Hasegawa T
Mod Pathol; 2007 Jul; 20(7):749-59. PubMed ID: 17464315
[TBL] [Abstract][Full Text] [Related]
6. Tail of Superficial Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma After Preoperative Radiotherapy.
Imanishi J; Slavin J; Pianta M; Jackett L; Ngan SY; Tanaka T; Charoenlap C; DI Bella C; Choong PF
Anticancer Res; 2016 May; 36(5):2339-44. PubMed ID: 27127141
[TBL] [Abstract][Full Text] [Related]
7. A novel imaging system permits real-time in vivo tumor bed assessment after resection of naturally occurring sarcomas in dogs.
Eward WC; Mito JK; Eward CA; Carter JE; Ferrer JM; Kirsch DG; Brigman BE
Clin Orthop Relat Res; 2013 Mar; 471(3):834-42. PubMed ID: 22972654
[TBL] [Abstract][Full Text] [Related]
8. Is the Thickness of the Margin Associated With Local Recurrence and Survival in Patients With Myxofibrosarcoma?
Yurtbay A; Coşkun HS; Say F; Dabak N
Clin Orthop Relat Res; 2023 Nov; 481(11):2125-2136. PubMed ID: 37249339
[TBL] [Abstract][Full Text] [Related]
9. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
[TBL] [Abstract][Full Text] [Related]
10. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of microscopic tumor extension in local recurrence of myxofibrosarcoma and undifferentiated pleomorphic sarcoma.
Song B; Lee K; Lee C; Moon KC
Pathol Int; 2018 Sep; 68(9):509-516. PubMed ID: 30094896
[TBL] [Abstract][Full Text] [Related]
12. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
[TBL] [Abstract][Full Text] [Related]
13. Review of primary superficial soft tissue mesenchymal tumors of malignant or intermediate biological potential.
Oettel DJ; Bernard SA
Skeletal Radiol; 2023 Mar; 52(3):435-445. PubMed ID: 35867123
[TBL] [Abstract][Full Text] [Related]
14. Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma.
Washimi K; Kasajima R; Shimizu E; Sato S; Okubo Y; Yoshioka E; Narimatsu H; Hiruma T; Katayama K; Yamaguchi R; Yamaguchi K; Furukawa Y; Miyano S; Imoto S; Yokose T; Miyagi Y
Sci Rep; 2023 Apr; 13(1):6744. PubMed ID: 37185612
[TBL] [Abstract][Full Text] [Related]
15. What is an adequate margin for infiltrative soft-tissue sarcomas?
Fujiwara T; Stevenson J; Parry M; Tsuda Y; Tsoi K; Jeys L
Eur J Surg Oncol; 2020 Feb; 46(2):277-281. PubMed ID: 31627932
[TBL] [Abstract][Full Text] [Related]
16. Cytopathology of myxofibrosarcoma: a study of 66 cases and literature review.
Wakely PE
J Am Soc Cytopathol; 2021; 10(3):300-309. PubMed ID: 33041221
[TBL] [Abstract][Full Text] [Related]
17. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic Liposarcoma: A Series of 120 Cases With Emphasis on Morphologic Variants.
Gjorgova Gjeorgjievski S; Thway K; Dermawan JK; John I; Fisher C; Rubin BP; Jenkins S; Thangaiah JJ; Folpe AL; Fritchie KJ
Am J Surg Pathol; 2022 Dec; 46(12):1700-1705. PubMed ID: 36006773
[TBL] [Abstract][Full Text] [Related]
19. The role of surgical margin quality in myxofibrosarcoma and undifferentiated pleomorphic sarcoma.
Fujiwara T; Sumathi V; Parry M; Stevenson J; Tsuda Y; Kaneuchi Y; Jeys L
Eur J Surg Oncol; 2021 Jul; 47(7):1756-1762. PubMed ID: 33342698
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.
Cordes C; Bartling B; Simm A; Afar D; Lautenschläger C; Hansen G; Silber RE; Burdach S; Hofmann HS
Lung Cancer; 2009 Apr; 64(1):79-85. PubMed ID: 18760860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
